These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
599 related articles for article (PubMed ID: 23384167)
1. The role of sequential 18(F) -FDG PET/CT in predicting tumour response after preoperative chemoradiation for rectal cancer. Sun W; Xu J; Hu W; Zhang Z; Shen W Colorectal Dis; 2013 May; 15(5):e231-8. PubMed ID: 23384167 [TBL] [Abstract][Full Text] [Related]
2. The predictive role of sequential FDG-PET/CT in response of locally advanced rectal cancer to neoadjuvant chemoradiation. Huh JW; Min JJ; Lee JH; Kim HR; Kim YJ Am J Clin Oncol; 2012 Aug; 35(4):340-4. PubMed ID: 21422901 [TBL] [Abstract][Full Text] [Related]
3. Neither FDG-PET Nor CT can distinguish between a pathological complete response and an incomplete response after neoadjuvant chemoradiation in locally advanced rectal cancer: a prospective study. Guillem JG; Ruby JA; Leibold T; Akhurst TJ; Yeung HW; Gollub MJ; Ginsberg MS; Shia J; Suriawinata AA; Riedel ER; Mazumdar M; Saltz LB; Minsky BD; Nash GM; Paty PB; Temple LK; Weiser MR; Larson SM Ann Surg; 2013 Aug; 258(2):289-95. PubMed ID: 23187748 [TBL] [Abstract][Full Text] [Related]
4. Comparison of (18)F-FDG PET/CT methods of analysis for predicting response to neoadjuvant chemoradiation therapy in patients with locally advanced low rectal cancer. Altini C; Niccoli Asabella A; De Luca R; Fanelli M; Caliandro C; Quartuccio N; Rubini D; Cistaro A; Montemurro S; Rubini G Abdom Imaging; 2015 Jun; 40(5):1190-202. PubMed ID: 25348731 [TBL] [Abstract][Full Text] [Related]
5. Prediction of tumor response after neoadjuvant chemoradiotherapy in rectal cancer using (18)fluorine-2-deoxy-D-glucose positron emission tomography-computed tomography and serum carcinoembryonic antigen: a prospective study. Li QW; Zheng RL; Ling YH; Wang QX; Xiao WW; Zeng ZF; Fan W; Li LR; Gao YH Abdom Radiol (NY); 2016 Aug; 41(8):1448-55. PubMed ID: 27116012 [TBL] [Abstract][Full Text] [Related]
6. Optimal timing for assessment of tumor response to neoadjuvant chemoradiation in patients with rectal cancer: do all patients benefit from waiting longer than 6 weeks? Perez RO; Habr-Gama A; São Julião GP; Gama-Rodrigues J; Sousa AH; Campos FG; Imperiale AR; Lynn PB; Proscurshim I; Nahas SC; Ono CR; Buchpiguel CA Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1159-65. PubMed ID: 22580120 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of ¹⁸F-FDG-PET for early detection of suboptimal response of rectal cancer to preoperative chemoradiotherapy: a prospective analysis. Leibold T; Akhurst TJ; Chessin DB; Yeung HW; Macapinlac H; Shia J; Minsky BD; Saltz LB; Riedel E; Mazumdar M; Paty PB; Weiser MR; Wong WD; Larson SM; Guillem JG Ann Surg Oncol; 2011 Oct; 18(10):2783-9. PubMed ID: 21476107 [TBL] [Abstract][Full Text] [Related]
8. 18F-FDG PET predicts pathological response to preoperative chemoradiotherapy in patients with primary rectal cancer: a meta-analysis. Li C; Lan X; Yuan H; Feng H; Xia X; Zhang Y Ann Nucl Med; 2014 Jun; 28(5):436-46. PubMed ID: 24623152 [TBL] [Abstract][Full Text] [Related]
9. Positron emission tomography for predicting pathologic response after neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Chennupati SK; Quon A; Kamaya A; Pai RK; La T; Krakow TE; Graves E; Koong AC; Chang DT Am J Clin Oncol; 2012 Aug; 35(4):334-9. PubMed ID: 21422989 [TBL] [Abstract][Full Text] [Related]
10. Prediction of response to neoadjuvant radiotherapy in patients with locally advanced rectal cancer by means of sequential 18FDG-PET. Everaert H; Hoorens A; Vanhove C; Sermeus A; Ceulemans G; Engels B; Vermeersch M; Verellen D; Urbain D; Storme G; De Ridder M Int J Radiat Oncol Biol Phys; 2011 May; 80(1):91-6. PubMed ID: 20605358 [TBL] [Abstract][Full Text] [Related]
11. Fifteen different 18F-FDG PET/CT qualitative and quantitative parameters investigated as pathological response predictors of locally advanced rectal cancer treated by neoadjuvant chemoradiation therapy. Maffione AM; Ferretti A; Grassetto G; Bellan E; Capirci C; Chondrogiannis S; Gava M; Marzola MC; Rampin L; Bondesan C; Colletti PM; Rubello D Eur J Nucl Med Mol Imaging; 2013 Jun; 40(6):853-64. PubMed ID: 23417501 [TBL] [Abstract][Full Text] [Related]
12. Does baseline [18F] FDG-PET/CT correlate with tumor staging, response after neoadjuvant chemoradiotherapy, and prognosis in patients with rectal cancer? Deantonio L; Caroli A; Puta E; Ferrante D; Apicella F; Turri L; Sacchetti G; Brambilla M; Krengli M Radiat Oncol; 2018 Oct; 13(1):211. PubMed ID: 30359275 [TBL] [Abstract][Full Text] [Related]
13. New application of dual point 18F-FDG PET/CT in the evaluation of neoadjuvant chemoradiation response of locally advanced rectal cancer. Yoon HJ; Kim SK; Kim TS; Im HJ; Lee ES; Kim HC; Park JW; Chang HJ; Choi HS; Kim DY; Oh JH Clin Nucl Med; 2013 Jan; 38(1):7-12. PubMed ID: 23242038 [TBL] [Abstract][Full Text] [Related]
14. Clinical implications of initial FDG-PET/CT in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy. Lee SJ; Kim JG; Lee SW; Chae YS; Kang BW; Lee YJ; Park JS; Choi GS Cancer Chemother Pharmacol; 2013 May; 71(5):1201-7. PubMed ID: 23420438 [TBL] [Abstract][Full Text] [Related]
15. PET-based treatment response evaluation in rectal cancer: prediction and validation. Janssen MH; Öllers MC; van Stiphout RG; Riedl RG; van den Bogaard J; Buijsen J; Lambin P; Lammering G Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):871-6. PubMed ID: 21377810 [TBL] [Abstract][Full Text] [Related]
16. Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy. Capirci C; Rampin L; Erba PA; Galeotti F; Crepaldi G; Banti E; Gava M; Fanti S; Mariani G; Muzzio PC; Rubello D Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1583-93. PubMed ID: 17503039 [TBL] [Abstract][Full Text] [Related]
17. Standardized Index of Shape (DCE-MRI) and Standardized Uptake Value (PET/CT): Two quantitative approaches to discriminate chemo-radiotherapy locally advanced rectal cancer responders under a functional profile. Petrillo A; Fusco R; Petrillo M; Granata V; Delrio P; Bianco F; Pecori B; Botti G; Tatangelo F; Caracò C; Aloj L; Avallone A; Lastoria S Oncotarget; 2017 Jan; 8(5):8143-8153. PubMed ID: 28042958 [TBL] [Abstract][Full Text] [Related]
18. Semiquantitative Volumetry by Sequential PET/CT May Improve Prediction of Complete Response to Neoadjuvant Chemoradiation in Patients With Distal Rectal Cancer. Dos Anjos DA; Perez RO; Habr-Gama A; São Julião GP; Vailati BB; Fernandez LM; de Sousa JB; Buchpiguel CA Dis Colon Rectum; 2016 Sep; 59(9):805-12. PubMed ID: 27505108 [TBL] [Abstract][Full Text] [Related]
19. Clinical relevance of positron emission tomography/computed tomography-positive inguinal nodes in rectal cancer after neoadjuvant chemoradiation. Perez RO; Habr-Gama A; São Julião GP; Proscurshim I; Ono CR; Lynn P; Bailão Aguilar P; Nahas SC; Gama-Rodrigues J; Buchpiguel CA Colorectal Dis; 2013 Jun; 15(6):674-82. PubMed ID: 23374979 [TBL] [Abstract][Full Text] [Related]
20. The value of 18F-FDG PET/CT for assessing the response to neoadjuvant therapy in locally advanced rectal cancer. Murcia Duréndez MJ; Frutos Esteban L; Luján J; Frutos MD; Valero G; Navarro Fernández JL; Mohamed Salem L; Ruiz Merino G; Claver Valderas MA Eur J Nucl Med Mol Imaging; 2013 Jan; 40(1):91-7. PubMed ID: 23081822 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]